2021/2744(DEA)
Conditions under which the commercial terms for clearing services for OTC derivatives are to be considered to be fair, reasonable, non-discriminatory and transparent
Basic information
2021/2744(DEA)
DEA - Delegated acts procedure
Supplementing 2010/0250(COD)
Subject
2.50.03 Securities and financial markets, stock exchange, CIUTS, investments
2.50.08 Financial services, financial reporting and auditing
2.50.10 Financial supervision
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 02/06/2021 | Non-legislative basic document published | C(2021)03817 | |
| 02/06/2021 | Initial period for examining delegated act 3.0 month(s) | ||
| 09/06/2021 | Committee referral announced in Parliament | ||
| 10/09/2021 | Delegated act not objected by Parliament |
Technical information
| Procedure reference | 2021/2744(DEA) |
|---|---|
| Procedure type | DEA - Delegated acts procedure |
| Procedure subtype | Examination of delegated act |
| Supplementing 2010/0250(COD) | |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ECON/9/06195
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2021)03817 02/06/2021 Document attached to the procedure C(2021)5607 23/07/2021